NEW DRUG APPROVALS























NEW DRUG APPROVALS OF JULY,2013
GENERIC NAME
BRAND NAME
USE
DATE OF APPROVAL
RASAGILINE MESYLATE TABLETS
AZILECT TABLETS
PARKINSON’S DISEASE
JULY 1  2013
DECITABINE INJECTION
DACOGEN INJECTION
MYELODYSPLASTIC SYNDROME
JULY 11 2013
REPAGLINIDE TABLETS USP
PRANDIN TABLETS
ORAL ANTIHYPERGLYCEMIC AGENT
JULY 11 2013
LAMOTRIGINE ORALLY DISTEGRATING TABLETS
LAMICTAL ODT
EPILEPSY
JULY 15 2013
ACAMPROSTATE CALCIUM DELAYED RELEASE TABLETS
CAMPRAL TABLETS
MAINTENANCE OF ABSISTENENCE FROM ALCOHOL IN PATIENTS WITH ALCOHOL DEPENDENCE
JULY 16 2013
TRETINONIN GEL USP
RETIN-A MICRO
ACNE VULGARIS
JULY 17 2013
FENOFIBRIC ACID DELAYED RELEASE CAPSULES
TRIPLIX DELAYED RELEASE CAPSULES

LIPID LOWERING AGENTS
JULY 18 2013
METFORMIN HYDROCHLORIC EXTENDED RELEASE TABLETS USP
GLUMETZA TABLETS
ORAL ANTIHYPERGLYCEMIC AGENT
JULY 19 2013
DONEPEZIL HYDROCHLORIC TABLETS
ARICEPT TABLETS
DEMENTIA,ALZHEIMER’S DISEASE
JULY 23 2013




Comments

Popular posts from this blog

FUNGAL DISEASES- solution CLOTRIMAZOLE

WORLD MENTAL HEALTH DAY 2019

ZIKA VIRUS : 4 LAKHS PEOPLE AFFECTED